KPDA focusing efforts on revising Pharmaceutical Affairs Law to fundamentally prevent unfair act using directly invested distribution companies

Published: 2017-09-20 14:58:14

Updated: 2017-09-20 14:58:14

The Korea Pharmaceutical Distribution Association(KPDA) decided to concentrate on revising the Pharmaceutical Affairs Law to fundamentally prevent unfair acts created by distribution companies directly invested by medical institutes.

The Korea Pharmaceutical Distribution Association(Chairman Chi-Yup Hwang) decided to take strong actions on some medical institutes which use loopholes of the law...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.